Vistin Pharma ASA (OSL:VISTN)
Norway · Delayed Price · Currency is NOK 18.35
+0.25 (1.38%)
At close: Oct 23, 2026
Vistin Pharma ASA Market Cap
Vistin Pharma ASA has a market cap or net worth of 813.72 million as of October 23, 2026. It is the 26,087th most valuable company in the world and the 180th biggest in Norway. Its market cap has decreased by 15.44% in one year.
Market Cap
813.72M
Enterprise Value
822.15M
Revenue
432.00M
Global Rank
Country Rank
#180 Norway
PE Ratio
11.59
ChartMarket Cap Chart
Since June 10, 2015, Vistin Pharma ASA's market cap has increased from 322.34M to 813.72M, an increase of 152.44%. That is a compound annual growth rate of 8.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 813.72M | -11.78% |
| Dec 30, 2025 | 922.37M | -12.24% |
| Dec 30, 2024 | 1.05B | 1.72% |
| Dec 29, 2023 | 1.03B | 47.47% |
| Dec 30, 2022 | 700.64M | -18.47% |
| Dec 30, 2021 | 859.40M | 11.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 5.49B |
| Circio Holding ASA | 3.16B |
| Nordhealth AS | 2.11B |
| Thor Medical ASA | 1.77B |
| ArcticZymes Technologies ASA | 1.04B |
| Nykode Therapeutics AS | 1.03B |
| Omda AS | 912.59M |
| INIFY Laboratories AB | 644.85M |